Continuous renal replacement therapy market

Continuous Renal Replacement Therapy Market Size, Share, Growth Analysis, By Product(System, Consumables), By Modality(Slow Continuous Ultra-Filtration (SCUF)), By End-user(Hospitals, Ambulatory Centers, Specially Clinics, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2403 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 88 |Figures: 76

Continuous Renal Replacement Therapy Market Insights

Continuous Renal Replacement Therapy Market size was valued at USD 1.2 Billion in 2021 and is poised to grow from USD 1.38 Billion in 2023 to USD 1.05 Billion by 2030, at a CAGR of 7.38% during the forecast period (2023-2030).

The market for Continuous Renal Replacement Therapy (CRRT) is expected to witness significant growth due to the high number of COVID-19 patients developing Acute Kidney Injury (AKI) and requiring CRRT. The demand for CRRT appears to be five times higher in COVID-19 patients compared to historical populations, leading to a surge in the utilization of CRRT during the pandemic. Initiatives taken by manufacturers and governments to increase awareness about CRRT and CKD have also contributed to market growth. The pandemic has created opportunities for local manufacturers, and the rising prevalence of fluid overload and improved patient outcomes are driving the demand for advanced CRRT devices. Additionally, the development of improved pediatric CRRT products is projected to fuel market expansion. The U.S. dominates the CRRT market, attributed to the rising prevalence of AKI, many hospitals, and a well-developed healthcare infrastructure. The increasing number of hospital admissions for AKI and the growing prevalence of end-stage renal disease further contribute to market growth in the U.S.

US Continuous Renal Replacement Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

Continuous Renal Replacement Therapy Market Segmental Analysis

The Continuous Renal Replacement Therapy (CRRT) Market can be analyzed based on various segments. These segments include Product (System and Consumables), Modality (Slow Continuous Ultra-Filtration - SCUF), Age Group (Adults), End Use, and Region. In terms of products, the market can be divided into CRRT systems and consumables. The modality segment focuses on Slow Continuous Ultra-Filtration (SCUF) as a form of CRRT. The market primarily caters to the adult age group. End-use categories encompass hospitals, dialysis centers, and other healthcare facilities. Geographically, the market is segmented into different regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Continuous Renal Replacement Therapy Market Analysis By Product Type

The consumables segment holds the largest share in the Continuous Renal Replacement Therapy (CRRT) market. This segment includes hemofilters, line sets, fluid/dialysate, and accessories, which are essential components for CRRT procedures. Companies like Baxter and Fresenius offer a range of consumables across different modalities to meet the needs of patients with renal diseases.

These machines play a crucial role in delivering renal therapy and incorporate features such as blood and fluid pumps, user-friendly interfaces, scales, and safety measures. Technological advancements, such as improved permeability and integration with Electronic Medical Record (EMR) systems, are driving the growth of this segment. Manufacturers are focusing on developing sophisticated devices that offer safe and consistent performance during CRRT procedures.

Continuous Renal Replacement Therapy Market Analysis By Modality

The Continuous Venovenous Hemofiltration (CVVH) segment holds the largest market share in the continuous renal replacement therapy (CRRT) market, accounting for 31.5% of the revenue in 2021. The prevalence of fluid overload cases in acute kidney injury patients in critical care units is a significant driver for the growth of the CVVH segment. Fluid overload is directly linked to conditions like congestive heart failure, which increases the demand for CVVH treatment. These factors are expected to contribute to the growth of the CVVH segment over the forecast period.

On the other hand, the Continuous Venovenous Hemodiafiltration (CVVHDF) segment is projected to witness the highest compound annual growth rate in the CRRT market. CVVHDF combines hemodialysis and hemofiltration modalities by using a highly efficient hemodiafilter to remove both fluid and solute from the blood. This treatment method offers complete removal and replacement of fluid and solute, making it the most widely used CRRT modality for acute kidney injury in various countries. The higher survival rate associated with CVVHDF compared to other CRRT modalities is expected to drive its market growth significantly during the forecast period.

Continuous Renal Replacement Therapy Market Application by End-User

The hospitals segment holds a significant share of the CRRT market and is expected to experience steady growth. Hospitals are the primary healthcare settings where CRRT is performed, especially in critical care units. The increasing prevalence of acute kidney injury (AKI) and the rising number of hospital admissions for renal diseases contribute to the growth of CRRT utilization in hospitals. Additionally, the availability of advanced CRRT machines and the presence of skilled medical professionals in hospitals further drive the growth of this segment.

The clinics segment is projected to witness substantial growth in the CRRT market. Dialysis clinics and specialized renal care clinics play a crucial role in providing CRRT services to patients with chronic kidney diseases (CKD) and end-stage renal disease (ESRD). The growing prevalence of CKD and ESRD, coupled with the increasing number of dialysis clinics worldwide, boosts the demand for CRRT in clinics. Moreover, clinics offer convenient and accessible treatment options for patients requiring CRRT, contributing to the growth of this segment.

To get detailed analysis on other segments, Request For Free Sample Report

Continuous Renal Replacement Therapy Market Regional Insights

North America dominated the continuous renal replacement therapy (CRRT) market with the highest revenue share of 35.6% in 2021. The region's market growth is driven by the increasing prevalence of the geriatric population and the rising incidence of kidney disorders. Unhealthy lifestyles and dietary habits, such as sedentary lifestyles and poor eating habits, contribute to the growing incidence of lifestyle-related diseases like kidney dysfunction, hypertension, and diabetes. In the United States, for example, millions of adults are estimated to have chronic kidney disease (CKD), creating a significant demand for CRRT. These factors contribute to the growth of the CRRT market in North America.

In the Asia Pacific region, the market for continuous renal replacement therapy is projected to experience a high compound annual during the forecast period. The region's growth is fueled by significant unmet medical needs related to diseases like diabetes, hypertension, and chronic kidney disease. The healthcare expenditure in the region is continually improving, enabling better access to CRRT and other medical treatments. China has emerged as an attractive market for medical devices. The Chinese government has implemented measures to support the medical manufacturing industry, such as reducing the Value Added Tax (VAT) for medical manufacturing companies

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Continuous Renal Replacement Therapy Market Dynamics

Drivers of the Continuous renal replacement therapy market:

  • Increasing Prevalence of Acute Kidney Injury (AKI): The rising incidence of AKI, particularly in critically ill patients and those with underlying health conditions. AKI is commonly observed in settings such as intensive care units, where CRRT is often used as a renal replacement therapy. The growing prevalence of AKI contributes to the demand for CRRT devices and consumables.
  • Technological Advancements in CRRT Systems: Continuous advancements in CRRT systems, including improved automation, enhanced safety features, and user-friendly interfaces, are driving market growth.
  • Increasing Awareness and Adoption of CRRT: There is a growing awareness among healthcare professionals about the benefits of CRRT in managing critically ill patients with renal dysfunction.

Restraints of the Continuous renal replacement therapy market:

  • High Cost of CRRT Treatment: The cost associated with CRRT treatment, including the equipment, consumables, and specialized healthcare professionals, can be significant. This cost burden can limit the adoption of CRRT, particularly in resource-constrained healthcare settings or regions with limited healthcare budgets. The high cost may pose challenges for widespread access to CRRT, hindering market growth.
  • Limited Availability in Developing Regions: CRRT treatment may not be readily available or accessible in all healthcare facilities, especially in developing regions with inadequate healthcare infrastructure. The lack of trained healthcare professionals, limited healthcare facilities equipped with CRRT systems, and logistical challenges in delivering CRRT treatment can impede market growth in these regions.
  • Alternative Renal Replacement Therapies: While CRRT is an effective renal replacement therapy, there are alternative modalities available, such as intermittent hemodialysis and peritoneal dialysis. These alternative therapies may have lower upfront costs, easier implementation, or better availability in certain healthcare settings. The presence of alternative treatment options can pose a challenge to the adoption and market penetration of CRRT.

Request Free Customization of this report to help us to meet your business objectives.

Continuous Renal Replacement Therapy Market Competitive Landscape

The competitive landscape of the Continuous Renal Replacement Therapy (CRRT) market is characterized by the presence of several key players striving for market dominance. Companies such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Corporation, NxStage Medical, Inc., Infomed SA, Medical Components, Inc., and Bellco S.r.l. are among the prominent players in the market. These companies focus on product innovations, strategic partnerships, mergers and acquisitions, and geographical expansions to gain a competitive edge. Additionally, the market also witnesses the presence of regional players who cater to specific geographical regions, further intensifying the competition.

Continuous Renal Replacement Therapy Market Top Player’s Company Profile

  • Medtronic plc - Ireland
  • Nikkiso Co., Ltd. - Japan
  • Asahi Kasei Corporation - Japan
  • NxStage Medical, Inc. - United States
  • Infomed SA - Switzerland
  • Medical Components, Inc. - United States
  • Bellco S.r.l. - Italy
  • Toray Medical Co., Ltd. - Japan
  • Medica S.p.A. - Italy
  • Medos Medizintechnik AG - Germany
  • Jafron Biomedical Co., Ltd. - China
  • Nipro Corporation - Japan
  • CytoSorbents Corporation - United States
  • SWS Hemodialysis Care Co., Ltd. - China
  • Aferetica S.r.l. - Italy
  • Terumo Corporation - Japan
  • Shanwaishan Science and Technology (Shenzhen) Co., Ltd. - China

Continuous Renal Replacement Therapy Market Recent Developments

  • 2021: Baxter International Inc. launched the PrisMax 2 system, the latest version of their next-generation CRRT platform, designed to meet the demands of Intensive Care Units (ICUs) and simplify organ support transfer.
  • Fresenius Medical Care AG & Co. KGaA announced the acquisition of Xenios AG, a company specializing in extracorporeal lung and heart support technologies, expanding their portfolio of critical care therapies.

Continuous Renal Replacement Therapy Key Market Trends

  • The Continuous Renal Replacement Therapy (CRRT) market is experiencing several key market trends. Firstly, there is a growing demand for CRRT devices and consumables due to the increasing prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) globally. The rising geriatric population and the high incidence of comorbidities such as diabetes and hypertension contribute to the demand for CRRT. Secondly, technological advancements are driving the market, with the development of advanced CRRT machines that offer improved efficiency, safety, and user-friendly interfaces. Integration of electronic medical record (EMR) connectivity and remote monitoring capabilities are enhancing patient care and treatment outcomes. Lastly, there is a rising focus on home-based CRRT, allowing patients to receive continuous renal replacement therapy in the comfort of their own homes. This trend is driven by the advantages of home-based therapy, including improved patient convenience, reduced hospital visits, and potentially lower healthcare costs. Overall, these market trends indicate a growing demand for CRRT and a shift towards more advanced and patient-centric treatment approaches.

Continuous Renal Replacement Therapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the Continuous Renal Replacement Therapy (CRRT) market is expected to witness significant growth in the future. Several factors contribute to this growth. Firstly, the increasing prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) is driving the demand for CRRT. The rising geriatric population, growing incidence of comorbidities, and the need for renal replacement therapy in critical care settings are fueling market growth. Secondly, advancements in technology, such as the development of more efficient and user-friendly CRRT machines, are enhancing the adoption of CRRT. Integration of electronic medical record (EMR) connectivity and remote monitoring capabilities further contribute to market growth. Thirdly, the trend towards home-based CRRT is expected to expand, providing patients with the convenience and flexibility of receiving treatment in their own homes. Lastly, favorable government initiatives and increased healthcare spending in developing economies are creating opportunities for market expansion. Overall, the future growth of the CRRT market is driven by the increasing demand for renal replacement therapy, technological advancements, and evolving treatment approaches.

What’s Included

NA

Report Metric Details
Market size value in 2023 USD 1.2 Billion
Market size value in 2031 USD 1.05 Billion
Growth Rate 7.38%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • System, Consumables
  • Modality
    • Slow Continuous Ultra-Filtration (SCUF)
  • End-user
    • Hospitals, Ambulatory Centers, Specially Clinics, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic plc - Ireland
  • Nikkiso Co., Ltd. - Japan
  • Asahi Kasei Corporation - Japan
  • NxStage Medical, Inc. - United States
  • Infomed SA - Switzerland
  • Medical Components, Inc. - United States
  • Bellco S.r.l. - Italy
  • Toray Medical Co., Ltd. - Japan
  • Medica S.p.A. - Italy
  • Medos Medizintechnik AG - Germany
  • Jafron Biomedical Co., Ltd. - China
  • Nipro Corporation - Japan
  • CytoSorbents Corporation - United States
  • SWS Hemodialysis Care Co., Ltd. - China
  • Aferetica S.r.l. - Italy
  • Terumo Corporation - Japan
  • Shanwaishan Science and Technology (Shenzhen) Co., Ltd. - China
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Continuous Renal Replacement Therapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Continuous Renal Replacement Therapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Continuous Renal Replacement Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Continuous Renal Replacement Therapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Continuous Renal Replacement Therapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Continuous Renal Replacement Therapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Continuous Renal Replacement Therapy Market size was valued at USD 1.2 Billion in 2021 and is poised to grow from USD 1.38 Billion in 2023 to USD 1.05 Billion by 2030, at a CAGR of 7.38% during the forecast period (2023-2030).

The competitive landscape of the Continuous Renal Replacement Therapy (CRRT) market is characterized by the presence of several key players striving for market dominance. Companies such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Corporation, NxStage Medical, Inc., Infomed SA, Medical Components, Inc., and Bellco S.r.l. are among the prominent players in the market. These companies focus on product innovations, strategic partnerships, mergers and acquisitions, and geographical expansions to gain a competitive edge. Additionally, the market also witnesses the presence of regional players who cater to specific geographical regions, further intensifying the competition. 'Baxter International Inc. - United States', 'Fresenius Medical Care AG & Co. KGaA - Germany', 'B. Braun Melsungen AG - Germany', 'Medtronic plc - Ireland', 'Nikkiso Co., Ltd. - Japan', 'Asahi Kasei Corporation - Japan', 'NxStage Medical, Inc. - United States', 'Infomed SA - Switzerland', 'Medical Components, Inc. - United States', 'Bellco S.r.l. - Italy', 'Toray Medical Co., Ltd. - Japan', 'Medica S.p.A. - Italy', 'Medos Medizintechnik AG - Germany', 'Jafron Biomedical Co., Ltd. - China', 'Nipro Corporation - Japan', 'CytoSorbents Corporation - United States', 'SWS Hemodialysis Care Co., Ltd. - China', 'Aferetica S.r.l. - Italy', 'Terumo Corporation - Japan', 'Shanwaishan Science and Technology (Shenzhen) Co., Ltd. - China'

Increasing Prevalence of Acute Kidney Injury (AKI): The rising incidence of AKI, particularly in critically ill patients and those with underlying health conditions. AKI is commonly observed in settings such as intensive care units, where CRRT is often used as a renal replacement therapy. The growing prevalence of AKI contributes to the demand for CRRT devices and consumables.

The Continuous Renal Replacement Therapy (CRRT) market is experiencing several key market trends. Firstly, there is a growing demand for CRRT devices and consumables due to the increasing prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) globally. The rising geriatric population and the high incidence of comorbidities such as diabetes and hypertension contribute to the demand for CRRT. Secondly, technological advancements are driving the market, with the development of advanced CRRT machines that offer improved efficiency, safety, and user-friendly interfaces. Integration of electronic medical record (EMR) connectivity and remote monitoring capabilities are enhancing patient care and treatment outcomes. Lastly, there is a rising focus on home-based CRRT, allowing patients to receive continuous renal replacement therapy in the comfort of their own homes. This trend is driven by the advantages of home-based therapy, including improved patient convenience, reduced hospital visits, and potentially lower healthcare costs. Overall, these market trends indicate a growing demand for CRRT and a shift towards more advanced and patient-centric treatment approaches.

North America dominated the continuous renal replacement therapy (CRRT) market with the highest revenue share of 35.6% in 2021. The region's market growth is driven by the increasing prevalence of the geriatric population and the rising incidence of kidney disorders. Unhealthy lifestyles and dietary habits, such as sedentary lifestyles and poor eating habits, contribute to the growing incidence of lifestyle-related diseases like kidney dysfunction, hypertension, and diabetes. In the United States, for example, millions of adults are estimated to have chronic kidney disease (CKD), creating a significant demand for CRRT. These factors contribute to the growth of the CRRT market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Continuous renal replacement therapy market

Product ID: SQMIG35A2403

$5,300
BUY NOW GET FREE SAMPLE